Sign in
4

Changes in Ownership

Zentalis Pharmaceuticals, Inc. Filed Acc 0000902664-23-003642

10% owner bought 4,760,000 shares at $22.66 ($107,861,600)

From the SEC's structured data for this filing

Trades in this filing

Matrix Capital Management Company, LP · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-06-20 Purchase : show line 1 in the form +4,760,000 $22.66 $107,861,600 13,959,973 I
Open-market purchases · 4,760,000 sh · avg $22.66 · $107,861,600
Loading xslF345X04/ownership.xml…